|
FR2763849B1
(fr)
|
1997-05-28 |
2000-09-15 |
Rhone Poulenc Rorer Sa |
Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
|
|
US20040018194A1
(en)
|
2000-11-28 |
2004-01-29 |
Francisco Joseph A. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
US7244764B2
(en)
|
2003-06-23 |
2007-07-17 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
RU2407752C2
(ru)
|
2004-04-29 |
2010-12-27 |
Оцука Фармасьютикал Ко., Лтд. |
Антитела к гликопротеину vi и способы продуцирования и использования этих антител
|
|
WO2005111283A1
(ja)
*
|
2004-05-17 |
2005-11-24 |
Denki Kagaku Kogyo Kabushiki Kaisha |
ポリ塩化ビニル繊維及びその製造方法並びに人工毛髪
|
|
KR20070094890A
(ko)
|
2004-10-25 |
2007-09-27 |
머크 앤드 캄파니 인코포레이티드 |
안티 ａｄｄｌ 항체 및 그 용도
|
|
TW200636064A
(en)
|
2004-10-28 |
2006-10-16 |
Centocor Inc |
Anti-respiratory syncytial virus antibodies, antigens and uses thereof
|
|
JP2009510105A
(ja)
|
2005-09-28 |
2009-03-12 |
バイオバスキュラー インコーポレーティッド |
血小板および細胞の接着、細胞移動、および炎症を阻止するための方法および組成物
|
|
SI3219328T1
(sl)
|
2005-12-29 |
2020-10-30 |
Janssen Biotech, Inc. |
Človeška protitelesa proti-IL-23, sestavki, postopki in uporabe
|
|
AU2007267561B2
(en)
|
2006-05-25 |
2012-05-17 |
Momenta Pharmaceuticals, Inc. |
Low molecular weight heparin composition and uses thereof
|
|
KR20100014588A
(ko)
|
2007-02-27 |
2010-02-10 |
제넨테크, 인크. |
길항제 ｏｘ40 항체 및 염증성 및 자가면역 질환의 치료에서의 이의 용도
|
|
US8685400B2
(en)
|
2007-07-30 |
2014-04-01 |
University Of Miami |
Modulating inflammasome activity and inflammation in the central nervous system
|
|
EP2300000A1
(en)
*
|
2008-07-03 |
2011-03-30 |
University of Massachusetts |
Methods and compositions for reducing inflammation and treating inflammatory disorders
|
|
EP2145624A1
(en)
|
2008-07-18 |
2010-01-20 |
Sanofi-Aventis |
Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
|
|
WO2011029931A1
(en)
|
2009-09-11 |
2011-03-17 |
Protaffin Biotechnologie Ag |
Composition for treatment of cxcl8-mediated lung inflammation
|
|
US8759302B2
(en)
|
2010-03-16 |
2014-06-24 |
Teva Pharmaceutical Industries, Ltd. |
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
|
|
SMT202000095T1
(it)
*
|
2010-05-14 |
2020-03-13 |
Amgen Inc |
Formulazioni di anticorpi anti-sclerostina ad alta concentrazione
|
|
IT1406201B1
(it)
|
2010-12-10 |
2014-02-14 |
Univ Degli Studi Trieste |
Biomarcatori per la diagnosi della sclerosi multipla
|
|
ES2578477T3
(es)
|
2011-03-11 |
2016-07-27 |
Roche Diagniostics Gmbh |
ASC como marcador de la enfermedad pulmonar obstructiva crónica (EPOC)
|
|
WO2013049278A1
(en)
|
2011-09-30 |
2013-04-04 |
Novartis Ag |
USE OF IL-1 ß BINDING ANTIBODIES
|
|
WO2013119673A1
(en)
|
2012-02-06 |
2013-08-15 |
University Of Miami |
Innate immune proteins as biomarkers for cns injury
|
|
TWI480044B
(zh)
|
2012-03-16 |
2015-04-11 |
Taichung Veterans General Hospital |
A high molecular weight heparin or low molecular weight heparin for the preparation of a composition for at least two consecutive days of administration to improve the allergic constitution
|
|
US20140314746A1
(en)
*
|
2013-03-13 |
2014-10-23 |
Philadelphia Health And Education Corporation, d/b/a Drexel University College of Medicine |
Methods for treating or preventing fibrosis in subjects afflicted with scleroderma
|
|
MX2015015784A
(es)
|
2013-05-17 |
2016-03-11 |
Genentech Inc |
Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.
|
|
JP6359013B2
(ja)
*
|
2013-07-29 |
2018-07-18 |
国立大学法人 鹿児島大学 |
１，５−ｄ−アンヒドロフルクトースを含むアポトーシス関連スペック様カード蛋白質の機能阻害薬
|
|
JP7066321B2
(ja)
|
2014-01-10 |
2022-05-13 |
アヴァリン ファーマ インク． |
エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
|
|
US10261098B2
(en)
|
2014-08-18 |
2019-04-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers for diagnosis and management of neuro-immunological diseases
|
|
CA2964315A1
(en)
|
2014-10-16 |
2016-04-21 |
Novartis Ag |
Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis
|
|
US20160263183A1
(en)
|
2015-03-10 |
2016-09-15 |
Brown University |
Methods for treating lung disease
|
|
CN114181281A
(zh)
|
2015-05-12 |
2022-03-15 |
加利福尼亚大学董事会 |
用于炎症和纤维化的肽治疗
|
|
JP6887987B2
(ja)
|
2015-08-17 |
2021-06-16 |
ティダブリューアイ・バイオテクノロジー・インコーポレイテッドＴＷＩ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． |
Ａｓｃの発現、ｎｌｒｐ３の発現、及び／又はｎｌｒｐ３インフラマソーム複合体の形成を阻害するためのジアセレイン又はそのアナログ
|
|
KR101948048B1
(ko)
|
2016-12-08 |
2019-02-14 |
한양대학교 에리카산학협력단 |
톡소포자충 ｇｒａ７ 항원 유래 재조합 단백질을 유효성분으로 포함하는 결핵 예방 또는 치료용 약학 조성물
|
|
WO2018126009A1
(en)
|
2016-12-29 |
2018-07-05 |
University Of Miami |
Method for modulating inflammasome activity and inflammation in the lung
|
|
US11840565B2
(en)
|
2016-12-29 |
2023-12-12 |
University Of Miami |
Methods and compositions for treating virus-associated inflammation
|
|
US10755739B1
(en)
|
2016-12-30 |
2020-08-25 |
John Fristrom |
Remote railway crossing programmable device and methods thereof
|
|
CN111356924A
(zh)
|
2017-09-20 |
2020-06-30 |
迈阿密大学 |
检测作为神经障碍生物标记的炎性体蛋白的方法
|
|
EP3818081A4
(en)
|
2018-07-03 |
2022-06-22 |
University of Miami |
COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME-RELATED DISEASES OR DISORDERS
|